当前位置：
X-MOL 学术
›
Blood Cancer J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2024-10-21 , DOI: 10.1038/s41408-024-01160-1 Niels W. C. J. van de Donk, Nizar Bahlis, Luciano J. Costa, María-Victoria Mateos, Ajay K. Nooka, Aurore Perrot, Alfred L. Garfall, Pragya Thaman, Keqin Qi, Clarissa Uhlar, Katherine Chastain, Margaret Doyle, Saad Z. Usmani
中文翻译：
在 1/2 期 MajesTEC-1 研究中，COVID-19 对复发/难治性多发性骨髓瘤患者 teclistamab 结果的影响
更新日期：2024-10-21
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2024-10-21 , DOI: 10.1038/s41408-024-01160-1 Niels W. C. J. van de Donk, Nizar Bahlis, Luciano J. Costa, María-Victoria Mateos, Ajay K. Nooka, Aurore Perrot, Alfred L. Garfall, Pragya Thaman, Keqin Qi, Clarissa Uhlar, Katherine Chastain, Margaret Doyle, Saad Z. Usmani
|
中文翻译：
在 1/2 期 MajesTEC-1 研究中，COVID-19 对复发/难治性多发性骨髓瘤患者 teclistamab 结果的影响
京公网安备 11010802027423号